Premium
Effects of Oral Administration of Stephania tetrandra S. Moore on Neovascularization of Retinal and Choroidal Capillaries of Diabetes in Rats
Author(s) -
Tsutsumi Taiki,
Hagino Nobuyoshi,
Liang Xiaochun,
Guo Saishan,
Kobayashi Shinjiro
Publication year - 2008
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2202
Subject(s) - streptozotocin , diabetes mellitus , retinal , endocrinology , medicine , in vivo , blood–retinal barrier , blood vessel , microcirculation , diabetic retinopathy , ophthalmology , biology , microbiology and biotechnology
In rats, an injection of streptozotocin (STZ) elevated blood levels of glucose 4 weeks later (STZ‐induced diabetes) and an over‐production of microvessels of retinal and choroidal capillaries of eyes developed. A previous study has shown that administration of Stephania tetrandra S. Moore (STSM) in culture prevented the over‐production of microvessels of those capillaries of STZ‐induced diabetes in vitro . Therefore, the study investigated whether or not orally administered STSM could inhibit over‐production of microvessels of those capillaries of STZ injected rats in vivo . When STSM was given at the same time as the STZ injection and continued daily for 7 weeks, STSM prevented the elevation of blood glucose level and over‐production of microvessels of those capillaries. When STSM was given after elevation of blood glucose level of glucose (4 weeks after STZ injection) and continued daily for 4 weeks, STSM lowered the elevated blood glucose level but had no effect on the over‐production of microvessels of those capillaries. It was inferred that deposition of N ϵ (carboxymethyl) lysine in retinal and choroidal tissues, which is induced by STZ‐induced diabetes may deteriorate the blood–retinal barrier and the blood–choroidal barrier. One might, therefore, speculate that advanced STZ‐induced diabetes may deteriorate the blood–retinal barrier and blood–choroidal barrier. Therefore, STSM may not reach the retinal and choroidal tissues in the posterior ocular region in vivo . Copyright © 2008 John Wiley & Sons, Ltd.